- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JH-06-0022488

Sabme Pharmaceuticals Private Limited
About Sabme Pharmaceuticals Private Limited
Data last updated:
Sabme Pharmaceuticals Private Limited is a private limited company based in Jamshedpur, Jharkhand, India. It operates in the engineering design and consultancy segment of the engineering sector. It was incorporated on 06 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74999JH2018PTC012244. Its GSTIN is 20ABBCS2343B1Z7 (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Resham Kaur and Rishab Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹8.32 Lakh (net margin 3.3%) and EBITDA of ₹28 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 28% over five years.
As per MCA filings, the company has open charges of ₹96.58 Lakh on record.
Sabme Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-06-0022488).
Company details
Recognitions & Rankings of Sabme Pharmaceuticals
Contact details
Sabme Pharmaceuticals Private Limited's registered office is in Jamshedpur, Jharkhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018
- IndustryEngineering, Engineering Design & Consultancy
To see the full contact details of Sabme Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sabme Pharmaceuticals Private Limited
FY 2025 filings availableSabme Pharmaceuticals Private Limited reported revenue of ₹2.53 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 6% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabme Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sabme Pharmaceuticals Private Limited
Sabme Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Resham Kaur Also directs: Seetri Pharmaceutical Private Limited | Director | 06 Dec 2018 | 7 Years 11 Months | Current |
| Rishab Agarwal | Director | 06 Dec 2018 | 7 Years 11 Months | Current |
Peer comparison
Sabme Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xiolife Pharmaceuticals and Healthcare Private Limited | ₹2.53 Cr (FY 2025) | 82.0% | Guwahati, Assam, India | |||
| Biomics Pharmaceuticals Private Limited | ₹2.53 Cr (FY 2025) | 3.0% | Karur, Tamil Nadu, India | |||
| Sabme Pharmaceuticals Private Limitedthis company | ₹2.53 Cr (FY 2025) | ₹8.32 Lakh | 3.3% | 6.0% | Jamshedpur, Jharkhand, India | |
| Novorem Pharmaceuticals Private Limited | ₹2.53 Cr (FY 2025) | 16.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sabme Pharmaceuticals Private Limited, buy the company report.
Auditor
Sabme Pharmaceuticals Private Limited is audited by SUMIT M AGARWAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUMIT M AGARWAL & CO | FY 2022 | 427015 |
Shareholding
The shareholding of Sabme Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sabme Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101091451 | Bank of India | ₹20 Lakh | Open | |
| 12 Mar 2025 | 101065122 | Bank of India | ₹9.5 Lakh | Open | |
| 12 Mar 2025 | 101065132 | Bank of India | ₹32 Lakh | Open | |
| 21 Jun 2022 | 100873914 | Hdfc Bank Limited | ₹21.08 Lakh | Open | |
| 03 Mar 2021 | 100444312 | Hdfc Bank Limited | ₹14 Lakh | Open |
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Sabme Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabme Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sabme Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20ABBCS2343B1Z7 | Jharkhand | Active | 25 Feb 2019 |
To see the full GST registrations and return filing status of Sabme Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sabme Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Indrajit Singh ceased to be Director on 26 Feb 2024.
Frequently asked questions
Sabme Pharmaceuticals is an active private limited company based in Jamshedpur, Jharkhand, India. The company works in engineering design and consultancy, within the engineering industry. It was incorporated on 06 December 2018 (8+ years old) and is registered under CIN U74999JH2018PTC012244.
Sabme Pharmaceuticals has 2 current directors:
- Resham Kaur - Director
- Rishab Agarwal - Director
The latest financial statements of Sabme Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Sabme Pharmaceuticals is 20ABBCS2343B1Z7, registered in Jharkhand.
The CIN (Corporate Identification Number) of Sabme Pharmaceuticals is U74999JH2018PTC012244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabme Pharmaceuticals was incorporated on 06 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Sabme Pharmaceuticals by revenue are Xiolife Pharmaceuticals and Healthcare Private Limited, Biomics Pharmaceuticals Private Limited, Novorem Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Indrajit Singh ceased to be Director on 26 Feb 2024. Resham Kaur was appointed as Director on 06 Dec 2018. Rishab Agarwal was appointed as Director on 06 Dec 2018.
Yes, Sabme Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-06-0022488).
The registered office of Sabme Pharmaceuticals is at Flat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018.
Sabme Pharmaceuticals operates in the engineering industry, in the engineering design and consultancy segment.

